OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
September 02, 2010
New data provide insight into pharma-industry professionals' daily lives.
Changing demands in drug development lead to new service combinations and models.
September 01, 2010
When embarking on a new outsourcing project, there are a few initial steps that must be taken to ensure a project runs smoothly from the start.
Bristol-Myers Squibb's fit-for-purpose mode for clinical-trial materials for early-stage development seeks to achieve a better way in resource allocation. This article is part of a special issue on API Development, Formulation, Synthesis and Manufacturing.
The current trend in the pharmaceutical industry for the manufacture of small-molecule therapeutic agents is moving toward continuous flow processes. This article is part of a special issue on APIs.
In an increasingly competitive landscape, outsourcing providers are under mounting pressure to get their name out there and secure new and repeat business.
The author presents recent developments in simulated moving-bed chromatography in production of active pharmaceutical ingredients and intermediates. This article is part of a special issue on APIs.
The author explains the background behind the excipient pedigree and how to implement its use.
The economic crisis has affected outsourcing providers in several ways.
India has evolved from a low-cost region to an area with extensive technical capability and high quality standards.